NCT00918515View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043

PHASE1CompletedINTERVENTIONAL

Enrollment

53

Participants

Timeline

Start Date

May 31, 2009

Study Completion Date

August 31, 2009

Conditions

Healthy

Interventions

DRUG

AZD3043

intravenous solution given once as intravenous infusion over 30 minutes

Trial Locations (1)

Unknown

Research Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY